Prenatal
In response to recent questions about exposure to products that may have been contaminated with listeria, we would like to remind providers of a testing and treatment algorithm that was developed by the IWK and RCP for pregnant patient with presumptive listeria exposure.
Pregnant patients with a positive blood culture for listeria should be referred to the Fetal Assessment & Treatment Centre (FATC) for surveillance.
Nova Scotia care providers have identified a need for additional information and guidance with assisting pregnant persons who choose self-pay non-invasive prenatal testing (NIPT). The following document provides information as a measure to assist with meeting this need.
This resource has been developed by care providers at IWK Health with contribution from the Reproductive Care Program. The goal is to offer prenatal care providers across Nova Scotia with an information resource that will guide pregnant persons regarding fetal movement.
Feel free to print the resource for easy reference and / or posting within your clinical spaces.
These guidelines have been developed through consultation with Diagnostic Imaging and the Fetal Assessment & Treatment Centre at the IWK Health Centre. The goal is to provide optimal prenatal care while balancing the impact of hospital visits on the health of the public and our staff.
This practice resource provides prenatal care providers with screening and treatment guidance for anemia in pregnancy, based on evidence as of the date of the most recent version. The algorithm distinguishes between the types of anemia that may be encountered, presents the health professional with the most appropriate treatment options, and provides recommendations for follow-up assessments.
This questionnaire has been developed in the Perinatal Centre at the IWK to support the antenatal care providers of pregnant patients who test positive for COVID-19 (and who are isolating at home). As numbers increase it has become less feasible for health professionals to call patients daily to check in. Some language in the document is specific to the IWK facility, but feel free to adjust it to suit your facility’s needs if you think this would be helpful.
This practice resource, developed in September 2021 and revised in February 2022, provides information to care providers related to a new approach to GDM screening in Nova Scotia. The practice resource has been informed by evidence and has been adapted specifically to Nova Scotia’s context and population of pregnant persons. It includes the Diabetes Care Program of Nova Scotia GDM screening practice algorithm and information related to the interpretation of testing results.
The Nova Scotia Vaccine Expert Panel has updated resources for care providers to use with pregnant and breastfeeding individuals to guide discussion about COVID-19 vaccination. This information is specific to adult immunization.
Accurate assessment of gestational age is crucial:
Consistent approaches to gestational age assessment must also be taken to optimize accuracy.
